Challenges for molecular profiling of chronic fatigue syndrome

Author： Vernon Suzanne D Whistler Toni Aslakson Eric Rajeevan Mangalathu Reeves William C

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.2, 2006-03, pp. : 211-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Descriptors of Fatigue in Chronic Fatigue Syndrome

By Libman Eva Creti Laura Rizzo Dorrie Jastremski Melanie Bailes Sally Fichten Catherine S.

Journal of Chronic Fatigue Syndrome, Vol. 14, Iss. 3, 2008-01 ,pp. : 37-45

Haworth Press

Access to resources Recommend Favorite

Chronic fatigue syndrome: is there a role for non-antidepressant pharmacotherapy?

By Houdenhove Boudewijn Van Pae Chi-Un Luyten Patrick

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 215-223

Informa Healthcare

Access to resources Recommend Favorite

Chronic Fatigue Syndrome and the Central Nervous System

By Chen R Liang FX Moriya J Yamakawa J Sumino H Kanda T Akahashi T

The Journal of International Medical Research, Vol. 36, Iss. 5, 2008-09 ,pp. : 867-874

Field House Publishing

Access to resources Recommend Favorite

Chronic Fatigue Syndrome: Probable Pathogenesis and Possible Treatments

By Evengård B.

Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. : 2433-2446

Adis International

Access to resources Recommend Favorite